Cargando…

ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer

Prostate cancer (PCa) is the second most common killer among men in Western countries. Targeting androgen receptor (AR) signaling by androgen deprivation therapy (ADT) is the current therapeutic regime for patients newly diagnosed with metastatic PCa. However, most patients relapse and become resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fararjeh, AbdulFattah Salah, Liu, Yen-Nien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600524/ https://www.ncbi.nlm.nih.gov/pubmed/31181727 http://dx.doi.org/10.3390/ijms20112802

Ejemplares similares

Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802
por: Fararjeh, Abdul-Fattah Salah, et al.
Publicado: (2020)

Upregulation of SPDEF is associated with poor prognosis in prostate cancer
por: Meiners, Jan, et al.
Publicado: (2019)

The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients
por: Salah Fararjeh, AbdulFattah, et al.
Publicado: (2021)

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer
por: Vatanmakanian, Mousa, et al.
Publicado: (2023)

New ideas in preventing castration-resistant prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2017)

GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration
por: Tamura, Rodrigo E., et al.
Publicado: (2016)

Transcriptional Regulation by ATOH1 and its Target SPDEF in the Intestine
por: Lo, Yuan-Hung, et al.
Publicado: (2016)

SPDEF Inhibits Prostate Carcinogenesis by Disrupting a Positive Feedback Loop in Regulation of the Foxm1 Oncogene
por: Cheng, Xin-Hua, et al.
Publicado: (2014)

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018)

Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency
por: Wen, Yu-Ching, et al.
Publicado: (2022)

Spdef deletion rescues the crypt cell proliferation defect in conditional Gata6 null mouse small intestine
por: Aronson, Boaz E, et al.
Publicado: (2014)

The subtype‐specific molecular function of SPDEF in breast cancer and insights into prognostic significance
por: Ye, Ting, et al.
Publicado: (2021)

Ly6D(+)Siglec-H(+) precursors contribute to conventional dendritic cells via a Zbtb46(+)Ly6D(+) intermediary stage
por: Lutz, Konstantin, et al.
Publicado: (2022)

Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages
por: Satpathy, Ansuman T., et al.
Publicado: (2012)

Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin
por: Satpathy, Ansuman T., et al.
Publicado: (2018)

Zbtb1 controls NKp46(+) ROR-gamma-T(+) innate lymphoid cell (ILC3) development
por: Lu, Ying, et al.
Publicado: (2017)

Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements
por: Papadopoulou, Vasiliki, et al.
Publicado: (2023)

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
por: Luk, Ian Y., et al.
Publicado: (2018)

Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD
por: Song, J., et al.
Publicado: (2017)

Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2020)

BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27
por: He, Jin, et al.
Publicado: (2020)

Portrait of Molecular Signaling and Putative Therapeutic Targets in Prostate Cancer with ETV4 Fusion
por: Shin, Ye Ji, et al.
Publicado: (2022)

Differential Expression and Prognostic Significance of STARD3 Gene in Breast Carcinoma
por: Fararjeh, Abdul Fattah Salah, et al.
Publicado: (2021)

Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model
por: Rombouts, Miche, et al.
Publicado: (2017)

CircZBTB46 Protects Acute Myeloid Leukemia Cells from Ferroptotic Cell Death by Upregulating SCD
por: Long, Fei, et al.
Publicado: (2023)

ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment
por: Villar, Javiera, et al.
Publicado: (2022)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer
por: de Dieuleveult, Maud, et al.
Publicado: (2020)

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
por: Bae, Song Yi, et al.
Publicado: (2023)

Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
por: Meredith, Matthew M., et al.
Publicado: (2012)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
por: Acar, Ömer, et al.
Publicado: (2013)

A Genetic Variant of p53 Restricts the Mucus Secretory Phenotype by Regulating SPDEF and Bcl-2 Expression
por: Chand, Hitendra S., et al.
Publicado: (2014)

SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1
por: Wang, Yanting, et al.
Publicado: (2021)

Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
por: Daoud, Georges, et al.
Publicado: (2016)

Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer
por: Kase, Adam M, et al.
Publicado: (2020)

Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based immunohistochemical study
por: Al Khader, Ali, et al.
Publicado: (2022)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
por: Attard, G, et al.
Publicado: (2008)

Identification and characterization of novel ETV4 splice variants in prostate cancer
por: Cosi, Irene, et al.
Publicado: (2023)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uea6hc4ceqon5kmg5cq3jtrho1